stock downgrade

Oppenheimer Downgrades Invitae to Perform Rating

BTIG Downgrades Fulgent Genetics from Buy to Neutral

JP Morgan Rates Invitae Neutral

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

OncoCyte Downgraded to Neutral by Piper Sandler on Unsuccessful Results for Lung Cancer Test

Barclays Downgrades Quest Diagnostics to Equal Weight

Evercore ISI Upgrades PerkinElmer, Downgrades Hologic

GenMark Diagnostics Downgraded by JP Morgan to Neutral

Luminex, Accelerate Diagnostics Downgraded by JP Morgan to Underweight

Qiagen Stock Downgraded to 'In Line' by Evercore ISI

Cowen Downgrades Myriad Genetics' Stock

LabCorp Downgraded by Canaccord Genuity

Vermillion Downgraded by Canaccord to Hold Rating

NeoGenomics Downgraded to Equal-Weight by First Analysis

Broader Markets Drag Down Stocks of Diagnostics Firms

Shares of Diagnostic Firms, Led by Exact Sciences, Outperform Broader Stock Market in 2017

2017 Ends on Down Beat for Diagnostic Firms as Shares Retreat in December

JP Morgan Downgrades Genomic Health to Underweight

Cowen Downgrades NanoString to Market Perform on Preannouncement of 'Huge Q3 Miss'

Stocks of Diagnostics Firms End Summer With Sluggish September